Otolaryngology Doctors in Federal Way, WA Accepting Medicare

9 Otolaryngology doctors found. Showing 1 - 9

Daniel W Kozie, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 34612 6th Ave S, Federal Way, WA 98003 Phone: 253-661-2594    Fax: 253-661-2694

Ryan E Stern, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Suite 110, Federal Way, WA 98003 Phone: 253-661-2594

Rodney Teasley, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34509 9th Ave S Ste 202, Federal Way, WA 98003 Phone: 253-942-2270    Fax: 360-377-1558

David Michael Johnson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S Ste 200, Federal Way, WA 98003 Phone: 253-661-2520    Fax: 253-661-2694

Dr. Kirby J Lautman, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Suite 200, Federal Way, WA 98003 Phone: 253-661-2594    Fax: 253-661-2694

Mark B Emery, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Federal Way, WA 98003 Phone: 253-661-2594    Fax: 253-661-2694

Mark D Hegewald, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S, Suite 200, Federal Way, WA 98003 Phone: 253-661-2594    Fax: 253-661-2694

Tracy Peterson Eriksson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 33501 1st Way S, Federal Way, WA 98003 Phone: 253-838-2400    Fax: 253-874-1637

Dick L. Hoistad, M.D. Otolaryngology - Otology & Neurotology Medicare: Accepting Medicare Assignments Practice Location: 34612 6th Ave S Ste 200, Federal Way, WA 98003 Phone: 253-833-4050    Fax: 253-735-5083

News Archive

CIGNA fourth quarter shareholders' net income increases to $461 million

CIGNA Corporation today reported shareholders' net income of $461 million, or $1.69 per share, for the fourth quarter of 2010 compared with shareholders' net income of $330 million, or $1.19 per share, for the fourth quarter of 2009.

Experts offer insights into new class of migraine medications

As research continues to show progress towards minimizing the effects of headache disorders on patients' lives, Practical Neurology gathered insights from experts in the field at The American Headache Society 61st Annual Scientific Meeting this year, where new data looking at a range of approaches from nerve stimulation to monoclonal antibodies and neuromodulation devices revealed advancements in migraine treatment.

GTx presents quality of life results from Ostarine Phase IIb study in cancer cachexia patients at ASCO 2010

GTx, Inc. today presented additional results from the Ostarine™ Phase IIb study demonstrating an improvement in quality of life (fatigue and anorexia) in cancer patients with muscle wasting (cancer cachexia) who demonstrated improvement in functional performance as measured by stair climb. Ostarine (GTx-024) is GTx's lead selective androgen receptor modulator (SARM) which the company is developing for the treatment of cancer cachexia.

Health care reform should benefit shift workers: Circadian Age

Circadian Age, Inc. – ‘Working Nights' – a company dedicated to helping shift workers and their families adjust to their unique lifestyles, is concerned with making sure that any health care reform will benefit the 25 million Americans working shifts. These workers represent 10% of the insured population, but incur 17% of the health care costs.

Follow the money trail to track the disease

It seems that a popular Web site in the United States that tracks the geographical circulation of money could cast new light on predicting where infectious diseases like bird flu might pop up.

Read more Medical News

› Verified 3 days ago